![]() |
![]() |
![]() |
|||
![]()
|
Issues archive
|
![]() Invista and its partner have decided to deploy INVISTA’s most advanced adiponitrile (ADN) technology at the Butachimie joint venture in France. Owned by Invista and Solvay, Butachimie is the largest ADN facility in the world. INVISTA’s new technology will be implemented by retrofitting the existing facilities during a planned turnaround in the second quarter of 2019. The new technology, already deployed and proven at INVISTA’s facility in Orange, Texas, extends Invista’s market-leading ADN technology in several aspects, including improved product yields, reduced energy consumption, lower greenhouse gas emissions, enhanced process stability and reduced capital intensity, compared to existing technologies. Invista will also implement its latest-generation ADN technology at its nylon intermediates facility in Victoria, Texas, pending final internal and regulatory approvals. Implementation is scheduled for the fourth quarter of 2020. In China, the company has received strong interest from customers and others in the value chain seeking to participate with Invista in building a new ADN plant at the Shanghai Chemical Industry Park, where Invista opened a 215,000-ton hexamethylene diamine (HMD) plant and a 150,000-ton polymer plant in 2016. The company is assessing this approach. As the preferred supplier for ADN, Invista supports growth and innovation in the nylon industry by continually investing in research and development, including the continued improvement of its ADN technology. The new ADN technology is the result of more than $40 million in research and development spanning four years on two continents.
All rights reserved. No information from the web site may be reproduced without the permission of the magazine's editorial board.
© Eurasian chemical market, 2005-2023 |
|||